Concepedia

Author

Tal Zaks

Moderna Therapeutics (United States)

Also Known As

Marjorie Hurley, T Z Zaks, T Zaks, T. Z. Zaks, T. Zaks, Tal Z Zaks, Tal Z. Zaks, Tal Zaks

101

Publications

10.2K

Citations

32

H-Index

79

Concepts

All Affiliations

Moderna Therapeutics (United States)GlaxoSmithKline (United States)National Cancer InstituteUPMC Hillman Cancer CenterSarah Cannon
TZ

About

Tal Zaks is an author at Moderna Therapeutics (United States) specializing in medicine, immunology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

26

3.3K

2

Health Sciences

7

7

285

3

Cell Biology

6

6

1.4K

4

Public Health

1

1

12

5

Diagnostic Sciences

1

1

36

Tal Zaks

×

41

Publications

6.2K

Citations

28

H-Index

YearCitations

Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects

David A. Tuveson, Alice T. Shaw, Nicholas A. Willis,

Cancer Cell

2004

809

Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses

Kapil Bahl, Joe J. Senn, Olga Yuzhakov,

Molecular Therapy

2017

646

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study

Jeffrey S. Weber, Matteo S. Carlino, Adnan Khattak,

The Lancet

2024

598

mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials

Robert Feldman, Rainard Fuhr, Igor Smolenov,

Vaccine

2019

453

mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer

Gal Cafri, Jared J. Gartner, Tal Zaks,

Journal of Clinical Investigation

2020

389

Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases

Fawn Qian, Stefan Engst, Peiwen Yu,

Cancer Research

2009

336

Cancer therapy using a self-replicating RNA vaccine

Ying Han, Tal Zaks, Rong‐Fu Wang,

Nature Medicine

1999

323

Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer

Amir Massarweh, Noa Eliakim‐Raz, Amos Stemmer,

JAMA Oncology

2021

282

Immunization with a peptide epitope (p369-377) from HER-2/neu leads to peptide-specific cytotoxic T lymphocytes that fail to recognize HER-2/neu+ tumors.

Tal Zaks, Steven A. Rosenberg

PubMed

1998

219

High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization

Tara L. Naylor, Joel Greshock, Yan Wang,

Breast Cancer Research

2005

210

Page 1